carvedilol has been researched along with Complications of Diabetes Mellitus in 9 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "To assess the efficacy and tolerability of carvedilol administration in patients with heart failure and concomitant diabetes." | 7.72 | Efficacy and tolerability of the long-term administration of carvedilol in patients with chronic heart failure with and without concomitant diabetes mellitus. ( Dei Cas, A; Dei Cas, L; Metra, M; Nodari, S, 2003) |
| " Based on this evidence, it is now recommended to add beta-blockers such as metoprolol CR/XL with an escalating dosage regimen to the treatment of patients with symptomatic heart failure who already are receiving a stable medical regimen including angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, diuretics, vasodilators, or digitalis." | 6.43 | The use of metoprolol CR/XL in the treatment of patients with diabetes and chronic heart failure. ( De Freitas, O; Fornoni, A; Lenz, O; Materson, BJ, 2006) |
| "This prospective post-marketing drug use survey was conducted to assess the safety and efficacy of the β-adrenergic receptor antagonist (β-blocker) Artist® Tablets (carvedilol) in patients with hypertension in Japan." | 3.77 | Artist® tablets (carvedilol) for hypertensive patients in Japan: results of a drug use survey. ( Hiramatsu, K; Iizuka, T; Komiya, M; Matsumoto, T; Mori, Y; Nishikawa, Y; Zenimura, N, 2011) |
| "To assess the efficacy and tolerability of carvedilol administration in patients with heart failure and concomitant diabetes." | 3.72 | Efficacy and tolerability of the long-term administration of carvedilol in patients with chronic heart failure with and without concomitant diabetes mellitus. ( Dei Cas, A; Dei Cas, L; Metra, M; Nodari, S, 2003) |
| " Based on this evidence, it is now recommended to add beta-blockers such as metoprolol CR/XL with an escalating dosage regimen to the treatment of patients with symptomatic heart failure who already are receiving a stable medical regimen including angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, diuretics, vasodilators, or digitalis." | 2.43 | The use of metoprolol CR/XL in the treatment of patients with diabetes and chronic heart failure. ( De Freitas, O; Fornoni, A; Lenz, O; Materson, BJ, 2006) |
| "The incidence of congestive heart failure is higher in diabetic patients, although the reasons for this increased rate are debated (higher incidence and severity of coronary heart disease and arterial hypertension, or a true diabetic cardiomyopathy)." | 2.41 | [Prevention and treatment of congestive heart failure in diabetic patients]. ( Anguita Sánchez, M, 2002) |
| "We used the non-obese, type 2 diabetes model Spontaneously Diabetic Torii (SDT) rats in this study." | 1.37 | Carvedilol ameliorates low-turnover bone disease in non-obese type 2 diabetes. ( Fujii, H; Fukagawa, M; Goto, S; Hamada, Y; Kitazawa, R; Kitazawa, S; Kono, K; Nakai, K; Nishi, S; Shinohara, M; Yamato, H, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (66.67) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Szentes, V | 1 |
| Kovács, G | 1 |
| Dézsi, CA | 1 |
| Giles, TD | 1 |
| Mori, Y | 1 |
| Nishikawa, Y | 1 |
| Iizuka, T | 1 |
| Zenimura, N | 1 |
| Matsumoto, T | 1 |
| Hiramatsu, K | 1 |
| Komiya, M | 1 |
| Goto, S | 1 |
| Fujii, H | 1 |
| Kono, K | 1 |
| Nakai, K | 1 |
| Hamada, Y | 1 |
| Yamato, H | 1 |
| Shinohara, M | 1 |
| Kitazawa, R | 1 |
| Kitazawa, S | 1 |
| Nishi, S | 1 |
| Fukagawa, M | 1 |
| Anguita Sánchez, M | 1 |
| Nodari, S | 1 |
| Metra, M | 1 |
| Dei Cas, A | 1 |
| Dei Cas, L | 1 |
| Bell, DS | 1 |
| Mizuta, Y | 1 |
| Imaizumi, T | 1 |
| De Freitas, O | 1 |
| Lenz, O | 1 |
| Fornoni, A | 1 |
| Materson, BJ | 1 |
6 reviews available for carvedilol and Complications of Diabetes Mellitus
| Article | Year |
|---|---|
[Practice of antihypertensive treatment in diabetic patients with hypertension in Hungary].
Topics: Adrenergic alpha-1 Receptor Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting En | 2014 |
Use of beta-blockers for heart failure in patients with diabetes mellitus.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Bisoprolol; Carbazoles; Carvedilol; Diabetes C | 2002 |
[Prevention and treatment of congestive heart failure in diabetic patients].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Aged; Angiotensin II; Angiotensin | 2002 |
Advantages of a third-generation beta-blocker in patients with diabetes mellitus.
Topics: Adrenergic beta-Antagonists; Carbazoles; Carvedilol; Coronary Disease; Diabetes Complications; Human | 2004 |
[Alpha beta-blockers for patients with hypertension].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Antihypertensive Agents; Carbazoles; Carv | 2006 |
The use of metoprolol CR/XL in the treatment of patients with diabetes and chronic heart failure.
Topics: Adrenergic beta-Antagonists; Carbazoles; Carvedilol; Chronic Disease; Delayed-Action Preparations; D | 2006 |
3 other studies available for carvedilol and Complications of Diabetes Mellitus
| Article | Year |
|---|---|
Artist® tablets (carvedilol) for hypertensive patients in Japan: results of a drug use survey.
Topics: Adolescent; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and ove | 2011 |
Carvedilol ameliorates low-turnover bone disease in non-obese type 2 diabetes.
Topics: Adrenergic beta-Antagonists; Animals; Bone Diseases; Carbazoles; Carvedilol; Diabetes Complications; | 2011 |
Efficacy and tolerability of the long-term administration of carvedilol in patients with chronic heart failure with and without concomitant diabetes mellitus.
Topics: Adrenergic beta-Antagonists; Aged; Carbazoles; Cardiac Catheterization; Carvedilol; Chronic Disease; | 2003 |